Project Grant R01EY036475

Award Date 9/1/24
Completion Date 6/30/29
Dollars Obligated $380K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Morgantown, WV 26506, USA
Similar Awards
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will provide $1,241,223 to the University of Pittsburgh to investigate the genetic and epigenetic mechanisms underlying retinal development and congenital vision disorders. The research aims to: Dissect the molecular, cellular, and genomic effects of genetic mutations on retinal development using mouse models. Elucidate how transcription factors wire the chromatin...
This federal Project Grant award of $679,159 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) will support research to investigate the combined effects of aging and elevated intraocular pressure (IOP) on the development of glaucoma and retinal ganglion cell (RGC) transcriptome changes, and determine how epigenetic reprogramming using AAV2-delivered OSK (Oct4, Sox2, Klf4) can reverse these age- and glaucoma-induced changes to restore visual function. The...
The National Eye Institute (NEI) awarded a Project Grant under the Vision Research program (CFDA 93.867) to the University of Oklahoma Health Sciences Center to investigate the transfer of extracellular microRNAs (miRNAs) between retinal pigment epithelium (RPE) and microglia as a means of intercellular communication. The $1,298,882 award, with a project period from Sep 30, 2024 to Apr 30, 2028, aims to evaluate the use of engineered RPE-derived extracellular vesicles (EVs) as an...
The National Eye Institute (NEI) has awarded a 4-year, $624,230 Project Grant (CFDA 93.867 - Vision Research) to the University of California, Los Angeles (UCLA) to conduct research on the physiology of retinal degeneration. The project aims to: 1) document changes in rod photoreceptor function and their connections to bipolar cells as retinal degeneration progresses in mouse models, and 2) investigate the plasticity and mechanisms behind retinal remodeling that allows visual processing to be...
The National Eye Institute (NEI) awarded a $240,000 Project Grant (CFDA 93.867 - Vision Research) to Baylor College of Medicine to conduct research focused on "Characterization of the Nascent Retinal Proteome Regulating Hippo Signaling During Damage." The project aims to use cell type-specific metabolic labeling and purification techniques to identify the immediate molecular regulators of the Hippo signaling pathway in muller glial cells of the damaged mouse retina. This information is...
The National Eye Institute (NEI) awarded a $440,806 Project Grant under the Vision Research program (CFDA 93.867) to The Research Foundation for the State University of New York (RF SUNY) to investigate the role of the molecular chaperone p58IPK in protecting retinal neurons during the development of diabetic retinopathy. The research aims to define the in vivo function of p58IPK in regulating protein and lipid homeostasis through the integrated stress response and lipid glycosylation...
The U.S. National Eye Institute (NEI) awarded a $184,117 Project Grant (CFDA 93.867 - Vision Research) to Oakland University to determine the role of G-coupled protein receptors GPR31 and GPR39 in the pathogenesis of diabetic retinopathy. The project aims to investigate the affinities and substrate specificities of GPR31 and GPR39 for 12- and 15-HETE metabolites in retinal endothelial cells and Müller cells under normal and hyperglycemic conditions. It will also examine the effects of GPR31 or...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), provides $475,442 to the University of California, Los Angeles (UCLA) to investigate the mechanisms underlying the ingestion of photoreceptor outer segment tips by the retinal pigment epithelium (RPE). The research aims to use live-cell imaging and in vivo analysis to study the dynamic actin polymerization processes involved in this essential RPE function, which is critical for...
This Project Grant award of $684,891 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) will support research to address the challenge of interpreting the functional consequences of rare genetic variants of unknown significance in inherited retinal degenerations (IRDs). The key products and services to be delivered include: Developing and applying a high-throughput splicing assay to identify rare coding and non-coding variants that lead to aberrant pre-mRNA...
This National Eye Institute (NEI) Project Grant award under the Vision Research federal grant program (CFDA 93.867) provides $462,430 in funding to the University of Utah from March 1, 2025 to February 28, 2030. The project aims to understand the role of the basal body and daughter centriole linkage in photoreceptor biology and pathophysiology, with a focus on how disruptions to this linkage contribute to retinal degeneration and hearing loss. Key objectives include determining the impact of...

This $380,000 Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate the role of interphotoreceptor matrix proteoglycans in retinal homeostasis and retinitis pigmentosa.

The project aims to: 1) Explore how the proteoglycans IMPG1 and IMPG2 facilitate nutrient exchange between the retina and retinal pigment epithelium, and how mutations in these molecules lead to adult-onset retinitis pigmentosa; 2) Determine the mechanisms by which IMPG2 mutations cause childhood-onset retinitis pigmentosa and test gene therapy strategies; and 3) Identify how mutations affecting IMPG1 proteolysis lead to rod degeneration and retinitis pigmentosa.

The research will utilize newly developed mouse models based on human disease to elucidate the role of the extracellular matrix in retinal homeostasis and test potential therapeutic approaches for these blinding disorders. The award period runs from September 1, 2024 to June 30, 2029 and is being conducted by the West Virginia University Research Corporation.

Generated 7/1/25, 4:29 AM